Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Accounts Receivable : ¥71.9 Mil (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Beijing Bohui Innovation Biotechnology Group Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Beijing Bohui Innovation Biotechnology Group Co's accounts receivables for the quarter that ended in Mar. 2025 was ¥71.9 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Beijing Bohui Innovation Biotechnology Group Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 was 32.52.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Beijing Bohui Innovation Biotechnology Group Co's Net-Net Working Capital per share for the quarter that ended in Mar. 2025 was ¥-2.64.

Beijing Bohui Innovation Biotechnology Group Co Accounts Receivable Historical Data

The historical data trend for Beijing Bohui Innovation Biotechnology Group Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Bohui Innovation Biotechnology Group Co Accounts Receivable Chart

Beijing Bohui Innovation Biotechnology Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Receivable

Get a 7-Day Free Trial

148.46

92.11

75.92

53.90

58.58

Beijing Bohui Innovation Biotechnology Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Receivable	Get a 7-Day Free Trial															46.55	47.79	41.08	58.58	71.87

Beijing Bohui Innovation Biotechnology Group Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Beijing Bohui Innovation Biotechnology Group Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Beijing Bohui Innovation Biotechnology Group Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	71.866	/	201.657	*	91
=	32.52

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Beijing Bohui Innovation Biotechnology Group Co's accounts receivable are only considered to be worth 75% of book value:

Beijing Bohui Innovation Biotechnology Group Co's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2025 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(286.845	+	0.75 * 71.866	+	0.5 * 1026.039	-	2032.224
-	0	-	974.439)	/	816.900
=	-2.64

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Beijing Bohui Innovation Biotechnology Group Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Beijing Bohui Innovation Biotechnology Group Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Bohui Innovation Biotechnology Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Bohui Innovation Biotechnology Group Co Ltd (SZSE:300318) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097

Website

http://www.bohui-tech.com

Beijing Bohui Innovation Biotechnology Group Co Ltd is a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. The company focuses on the research and development, production, sales, and after-sales services of in vitro diagnostic products. The Company's business involved two segments: inspection and testing and biological products. The Biological segment generated the majority of its revenue which engaged in the research and development, production, and sales of blood products, the product range covers human blood albumin, human immunoglobulin, and human coagulation factor three categories of multiple varieties, basically covering the important varieties of blood products.

Executives

Niu Shu Hui	Executives
Di Xiao Feng	Director
Yang Qi	Director
Lu Xin Qun	Directors, executives
Zhang Lei	Director
Wan Zhang Geng	Executives
Song Rui	Directors, executives

Beijing Bohui Innovation Biotechnology Group Co Headlines

No Headlines